+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

UAE Cancer Diagnostics Market, By Product v/s Instruments, By Technology, By Application, By End User, By Region, Competition Forecast & Opportunities, 2027

  • PDF Icon


  • 73 Pages
  • August 2022
  • Region: United Arab Emirates
  • TechSci Research
  • ID: 5597109
Free Webex Call
10% Free customization

The Market Growth Can be Attributed to the Rapidly Increasing Incidences of Cancer, Mainly Breast Cancer Among the Female Population.

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The UAE cancer diagnostics market is projected to grow at a significant rate during the forecast period, 2023-2027. The market growth can be attributed to the rapidly increasing incidences of cancer, mainly breast cancer among the female population. Besides, rising government efforts for advancing healthcare facilities in the country to provide treatment and patient care to cancer patients are also anticipated for the UAE cancer diagnostics market.

The healthcare sector is well developed in the United Arab Emirates. The UAE cancer diagnostics market will increase over the next five years on account of the growing requirement for technologically advanced methods, instruments, medical devices, kits, and reagents for the progress in the diagnostic process. The number of cancer cases in the nation has increased recently. 4807 new cancer cases were found in the year 2020. The majority of newly diagnosed cancer cases-about 21.4 percent, or 1030 cases-were for breast cancer.

The population is now more concerned than ever about the importance of routine exams and tests to look for any signs of cancer at the early stage. Rising demand for early cancer detection and assessment of its severity and increased need for regular exams and testing are also expected to fuel the UAE cancer diagnostics market growth in the coming years.

The number of oncology-focused hospitals and cancer diagnostic facilities is constantly expanding throughout Dubai. The growth of the UAE cancer diagnostics market over the next five years will also be fueled by expanding oncology diagnostic and treatment infrastructure. These medical facilities make significant investments in the development of effective cancer diagnostic kits and reagents that are both swift and affordable in their ability to identify cancer patients.

The UAE cancer diagnostics market is segmented based on the product, technology, application, end-user, competitional landscape, and regional distribution. Based on product, the market is divided between consumables and instruments. Instruments are anticipated to register the highest growth in the market during the forecast period owing to the higher costs of the medical devices and instruments utilized for cancer diagnosis.

Major players operating in the UAE cancer diagnostics market are GE Healthcare FZE, Abbott Laboratories S A, Roche Diagnostics Middle East FZCO, FUJIFILM Middle East FZE, Danaher Middle East LLC, Agilent Technologies UAE, Hologic Inc. UAE, among others.

Years considered for this report:

  • Historical Years: 2017-2020
  • Base Year: 2021
  • Estimated Year: 2022
  • Forecast Period: 2023-2027

Objective of the Study:

  • To analyze the historical growth in the market size of the UAE cancer diagnostics from 2017 to 2021.
  • To estimate and forecast the market size of UAE cancer diagnostics market from 2023 to 2027 and growth rate until 2027.
  • To classify and forecast the UAE cancer diagnostics market based on product, technology, application, end user, region, and company.
  • To identify the dominant region or segment in the UAE cancer diagnostics market.
  • To identify drivers and challenges for the UAE cancer diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the UAE cancer diagnostics market.
  • To identify and analyze the profiles of leading players operating in the UAE cancer diagnostics market.
  • To identify key sustainable strategies adopted by market players in UAE cancer diagnostics market.
The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of service providers across the country. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufacturers who could not be identified due to the limitations of secondary research. The publisher analyzed the service providers and presence of all major players across the country.

The publisher calculated the market size of the UAE cancer diagnostics market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:

  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, UAE cancer diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

UAE Cancer Diagnostics Market, By Product:

  • Consumable
  • Antibodies
  • Kits & Reagents
  • Probes
  • Others
  • Instruments
  • Pathology Instruments
  • Imaging Instruments
  • Biopsy Instruments

UAE Cancer Diagnostics Market, By Technology:

  • IVD Testing
  • Imaging
  • Biopsy

UAE Cancer Diagnostics Market, By Application:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others

UAE Cancer Diagnostics Market, By End User:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

UAE Cancer Diagnostics Market, By Region:

  • Abu Dhabi
  • Sharjah
  • Dubai
  • Rest of UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in UAE cancer diagnostics market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview2. Research Methodology3. Impact of COVID-19 on UAE Cancer Diagnostics Market4. Voice of Customer5. Executive Summary
6. UAE Cancer Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Consumable v/s Instruments)
6.2.2. By Technology (IVD Testing, Imaging, Biopsy)
6.2.3. By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Others)
6.2.4. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
6.2.5. By Company (2021)
6.2.6. By Region
6.3. Product Market Map
7. UAE Cancer Diagnostics Consumables Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Antibodies, Kits & Reagents, Probes, Others)
7.2.2. By Application
7.2.3. By End User
8. UAE Cancer Diagnostics Instruments Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Pathology Instruments, Imaging Instruments, Biopsy Instruments)
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
11. Competitive Landscape
11.1. GE Healthcare FZE
11.2. Abbott Laboratories S A
11.3. Roche Diagnostics Middle East FZCO
11.4. FUJIFILM Middle East FZE
11.5. Danaher Middle East LLC
11.6. Agilent Technologies UAE
11.7. Hologic Inc. UAE
12. Strategic Recommendations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • GE Healthcare FZE
  • Abbott Laboratories S A
  • Roche Diagnostics Middle East FZCO
  • FUJIFILM Middle East FZE
  • Danaher Middle East LLC
  • Agilent Technologies UAE
  • Hologic Inc. UAE